Brooks Laboratories Limited

BSE: 533543 NSE: BROOKS
Brooks Laboratories Limited - pharma in Nalagarh, Himachal Pradesh, India. FY 2026 financials and compliance.
CIN L24232HP2002PLC000267 Incorporated 23 January 2002 ROC Himachal Pradesh HQ Nalagarh, Himachal Pradesh, India
Active Listed - NSE: BROOKS · BSE: 533543 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹85.74 Cr
▲ 3.85% YoY
EBITDA · FY 2026
₹8.23 Cr
▲ 41.36% YoY
Net profit · FY 2026
₹24.58 Cr
▲ 346.65% YoY
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹29.46 Cr
Issued & subscribed
Open charges
₹75.81 Cr
Satisfied ₹115.74 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
289
Latest available

About Brooks Laboratories Limited

Data last updated: 21 December 2025

Brooks Laboratories Limited is a public limited company based in Nalagarh, Himachal Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 23 January 2002, the company has been in operation for over 24 years.

Registered with ROC Himachal Pradesh under CIN L24232HP2002PLC000267. Listed on BSE: 533543 and NSE: BROOKS.

Capital: an authorised share capital of ₹30 Cr and a paid-up capital of ₹29.46 Cr. It is led by directors including Bhushan Singh Rana and Jitendrapratap Rambahadur Singh.

Last AGM: 19 September 2024. Financial statements filed for year ended 31 March 2024. Office: Village Kishanpura Nalagarh Road Baddi, Himachal Pradesh, India – 174101.

As per the financials filed for FY 2025, the company reported a revenue of ₹83.44 Cr, a growth of 4% compared to the previous year.

The company has a workforce of approximately 289 employees as per the latest available data.

The company is associated with 1 brand - Brooks Laboratories. As per MCA filings, the company has open charges of ₹75.81 Cr and satisfied charges of ₹115.74 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brookslabs.net.

Company Details of Brooks Laboratories Limited
CIN L24232HP2002PLC000267
Registration Number 000267
Incorporation Date 23 January 2002
ROC Himachal Pradesh
Listing Status Listed (BSE: 533543, NSE: BROOKS)
Company Status Active
Date of Last AGM 19 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Bhushan Singh Rana Whole-Time Director Jitendrapratap Rambahadur Singh Whole-Time Director Durga Shankar Maity Whole-Time Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    brookslabs.net
  • Social Media
  • Registered Address
    Village Kishanpura Nalagarh Road Baddi, Himachal Pradesh, India – 174101
  • Industry
    Pharma, Drug Formulation & Development
Company report
Brooks Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Brooks Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Brooks Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Brooks Laboratories Limited

Brooks Laboratories Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24232HP2002PLC000267, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24232HP2002PLC000267 Current
U24232PB2002PLC024910 Previous
L24232PB2002PLC024910 Previous

Associated Brands with Brooks Laboratories Limited

Brooks Laboratories Limited operates one associated brand: Brooks Laboratories. These brands represent Brooks Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Brooks Laboratories
Manufacturer of pharmaceutical injectables, tablets, and oral suspensions brookslabs.net

Business Activity of Brooks Laboratories Limited

Brooks Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Brooks Laboratories Limited

Brooks Laboratories Limited is audited by DMKH & CO (ICAI peer reviewed, certificate valid till 2027-04-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
DMKH & CO (ICAI peer reviewed, certificate valid till 2027-04-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Brooks Laboratories Limited

Brooks Laboratories Limited is currently managed by 7 directors, with 26 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Bhushan Singh Rana
Also directs: Brooks Laboratories Limited
Whole-Time Director 23 Aug 2023 2 Years 10 Months Current
Jitendrapratap Rambahadur Singh
Also directs: Brooks Laboratories Limited
Whole-Time Director 23 Nov 2022 3 Years 7 Months Current
Durga Shankar Maity
Also directs: Brooks Laboratories Limited
Whole-Time Director 07 Jul 2023 3 Years 0 Months Current
Usha Singh
Also directs: Brooks Laboratories Limited
Director 07 Aug 2024 1 Years 11 Months Current
Manav Mahajan
Also directs: Brooks Laboratories Limited
Director 28 Sep 2024 1 Years 9 Months Current
Lalit Mahajan
Also directs: Brooks Laboratories Limited
Director 07 Aug 2024 1 Years 11 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Brooks Laboratories Limited FY 2026 filings available

Brooks Laboratories Limited reported revenue of ₹85.74 Cr (up 3.85% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹85.74 Cr ▲ 3.85%
Profit · FY 2026
₹24.58 Cr ▲ 346.65%
EBITDA · FY 2026
₹8.23 Cr ▲ 41.36%
Revenue₹ Cr · Consolidated050100FY 2021: ₹77 Cr77.2FY 2021FY 2022: ₹91 Cr · +17.9% YoY91.1+17.9%FY 2022FY 2023: ₹63 Cr · -30.6% YoY63.2-30.6%FY 2023FY 2024: ₹79 Cr · +25.8% YoY79.5+25.8%FY 2024FY 2025: ₹83 Cr · +3.9% YoY82.6+3.9%FY 2025FY 2026: ₹86 Cr · +3.9% YoY85.7+3.9%FY 2026
Net Profit₹ Cr · Consolidated-40-2002040FY 2021: ₹19 Cr (loss)-19.4FY 2021FY 2022: ₹19 Cr (loss) · +0.3% YoY-19.3FY 2022FY 2023: ₹32 Cr (loss) · -64.5% YoY-31.8FY 2023FY 2024: ₹20 Cr (loss) · +38.3% YoY-19.6FY 2024FY 2025: ₹10 Cr (loss) · +49.1% YoY-10FY 2025FY 2026: ₹25 Cr · +346.6% YoY24.6+346.6%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0102030Q1'25: ₹18 Cr · +14.2% YoY17.9+14.2%Q1'25Q2'25: ₹21 Cr · -14.5% YoY20.8-14.5%Q2'25Q3'25: ₹21 Cr · -5.7% YoY20.5-5.7%Q3'25Q4'25: ₹23 Cr · +31.6% YoY23.3+31.6%Q4'25Q1'26: ₹26 Cr · +42.3% YoY25.5+42.3%Q1'26Q2'26: ₹23 Cr · +12.8% YoY23.5+12.8%Q2'26Q3'26: ₹17 Cr · -19.2% YoY16.6-19.2%Q3'26Q4'26: ₹20 Cr · -13.3% YoY20.2-13.3%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue from Operations ₹85.74 Cr ₹82.56 Cr ₹79.49 Cr ₹63.2 Cr ₹91.08 Cr ₹77.25 Cr
Other Income ₹1.17 Cr ₹88.31 Lakh ₹95.56 Lakh ₹20.34 Lakh ₹90.91 Lakh ₹73.55 Lakh
Total Income ₹86.91 Cr ₹83.44 Cr ₹80.44 Cr ₹63.41 Cr ₹91.99 Cr ₹77.98 Cr
Cost of Materials Consumed ₹49.61 Cr ₹47.04 Cr ₹44.72 Cr ₹41.55 Cr ₹62.93 Cr ₹46.67 Cr
Purchases of Stock-in-Trade ₹2.25 Cr ₹7.18 Cr ₹10.5 Cr ₹4.87 Cr ₹1.96 Cr ₹4.24 Cr
Changes in Inventories -₹84.1 Lakh -₹14.79 Lakh ₹1.4 Cr ₹4.18 Cr -₹2.1 Cr -₹3.34 Cr
Employee Benefit Expense ₹15.16 Cr ₹12.96 Cr ₹10.54 Cr ₹17.34 Cr ₹19.15 Cr ₹14.37 Cr
Finance Costs ₹83.53 Lakh ₹1.03 Cr ₹84.49 Lakh ₹2.18 Cr ₹3.1 Cr ₹3.1 Cr
Depreciation & Amortisation ₹1.59 Cr ₹1.6 Cr ₹1.77 Cr ₹7.03 Cr ₹7.35 Cr ₹7.14 Cr
Other Expenses ₹12.49 Cr ₹10.58 Cr ₹9.11 Cr ₹21.68 Cr ₹23.5 Cr ₹14.78 Cr
Total Expenses ₹81.1 Cr ₹80.25 Cr ₹78.89 Cr ₹98.83 Cr ₹115.88 Cr ₹86.97 Cr
Profit Before Exceptional Items & Tax ₹5.81 Cr ₹3.19 Cr ₹1.55 Cr -₹35.42 Cr -₹23.9 Cr -₹8.99 Cr
Exceptional Items ₹0 ₹0 ₹0 -₹35.67 Lakh ₹0 ₹0
Profit Before Tax ₹5.81 Cr ₹3.19 Cr ₹1.55 Cr -₹35.78 Cr -₹23.9 Cr -₹8.99 Cr
Total Tax Expense ₹0 ₹17.54 Lakh ₹2.59 Lakh -₹7.32 Cr -₹4.59 Cr ₹10.38 Cr
Net Profit ₹24.58 Cr -₹9.97 Cr -₹19.59 Cr -₹31.77 Cr -₹19.31 Cr -₹19.38 Cr
  attributable to Owners ₹24.55 Cr - - -₹20.9 Cr -₹16.19 Cr -₹19.38 Cr
  attributable to NCI ₹0 - - -₹10.15 Cr -₹3.13 Cr ₹0
Other Comprehensive Income -₹3.07 Lakh -₹1.83 Lakh -₹4.34 Lakh -₹3.29 Lakh ₹6.54 Lakh ₹10.79 Lakh
Total Comprehensive Income ₹24.55 Cr -₹9.99 Cr -₹19.64 Cr -₹31.8 Cr -₹19.25 Cr -₹19.27 Cr
EBITDA (computed) ₹8.23 Cr ₹5.82 Cr ₹4.17 Cr -₹26.21 Cr -₹13.45 Cr ₹1.26 Cr
Basic EPS ₹8.35 ₹-3.72 ₹-7.67 ₹-12.57 ₹-7.82 ₹6.31
Diluted EPS ₹8.35 ₹-3.72 ₹-7.67 ₹-12.57 ₹-7.82 ₹6.31
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹148.17 Cr ₹123.69 Cr ₹90.45 Cr ₹109.6 Cr
Non-current Assets ₹110.76 Cr ₹89.82 Cr ₹59.4 Cr ₹81.99 Cr
Current Assets ₹37.42 Cr ₹33.88 Cr ₹31.05 Cr ₹27.61 Cr
Property, Plant & Equipment ₹13.41 Cr ₹12.51 Cr ₹13.07 Cr ₹14.02 Cr
Inventories ₹11.02 Cr ₹9.2 Cr ₹9.61 Cr ₹11.3 Cr
Trade Receivables ₹16.11 Cr ₹19.99 Cr ₹16.32 Cr ₹12.75 Cr
Cash & Equivalents ₹6.59 Cr ₹4.34 Lakh ₹12.55 Lakh ₹2.33 Lakh
Equity (Net Worth) ₹122.66 Cr ₹98.1 Cr ₹65.59 Cr ₹73.95 Cr
Equity Share Capital ₹29.46 Cr ₹29.46 Cr ₹26.25 Cr ₹24.7 Cr
Borrowings (Non-current) ₹1.19 Cr ₹13.05 Lakh ₹0 ₹0
Borrowings (Current) ₹6.09 Cr ₹5.93 Cr ₹5.04 Cr ₹5.66 Cr
Total Debt (computed) ₹7.28 Cr ₹6.06 Cr ₹5.04 Cr ₹5.66 Cr
Current Liabilities ₹21.81 Cr ₹22.84 Cr ₹23.05 Cr ₹33.02 Cr
Total Liabilities ₹25.52 Cr ₹25.59 Cr ₹24.86 Cr ₹35.64 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹9.29 Cr ₹2.52 Cr -₹9.68 Cr -₹14.49 Cr -₹37.44 Cr
Investing Cash Flow -₹2.92 Cr -₹45.97 Cr ₹18.22 Lakh ₹49.47 Lakh -₹24.91 Cr
Financing Cash Flow ₹17.09 Lakh ₹43.36 Cr ₹9.6 Cr ₹11.41 Cr ₹64.07 Cr
Capital Expenditure ₹3.51 Cr ₹92.28 Lakh ₹43.9 Lakh ₹46.75 Lakh ₹27.61 Cr
Free Cash Flow (computed) ₹5.79 Cr ₹1.6 Cr -₹10.12 Cr -₹14.96 Cr -₹65.05 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹6.54 Cr -₹8.21 Lakh ₹10.24 Lakh -₹2.58 Cr ₹1.72 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹20.21 Cr ₹16.57 Cr ₹23.45 Cr ₹25.51 Cr ₹23.32 Cr ₹20.52 Cr ₹20.79 Cr ₹17.93 Cr ₹17.72 Cr ₹21.75 Cr ₹24.32 Cr ₹15.7 Cr
Other Income ₹43.83 Lakh ₹12.5 Lakh ₹39.02 Lakh ₹21.7 Lakh ₹62.06 Lakh ₹2.79 Lakh ₹19.84 Lakh ₹6.93 Lakh ₹65.36 Lakh ₹15.5 Lakh ₹9.21 Lakh ₹5.48 Lakh
Total Income ₹20.65 Cr ₹16.69 Cr ₹23.84 Cr ₹25.73 Cr ₹23.94 Cr ₹20.54 Cr ₹20.99 Cr ₹18 Cr ₹18.38 Cr ₹21.9 Cr ₹24.41 Cr ₹15.76 Cr
Cost of Materials Consumed ₹11.81 Cr ₹9.08 Cr ₹10.42 Cr ₹13.62 Cr ₹13.68 Cr ₹12.17 Cr ₹11.4 Cr ₹9.8 Cr ₹9.74 Cr ₹12.09 Cr ₹12.23 Cr ₹10.67 Cr
Purchases of Stock-in-Trade ₹3.2 Lakh ₹1.49 Cr ₹3 Cr ₹2.41 Cr ₹1.72 Cr ₹1.19 Cr ₹1.24 Cr ₹3.03 Cr ₹3.11 Cr ₹2.9 Cr ₹3.63 Cr ₹86.09 Lakh
Changes in Inventories ₹57.39 Lakh -₹1.57 Cr ₹29.01 Lakh -₹13.13 Lakh ₹41.12 Lakh -₹59.51 Lakh ₹55.96 Lakh -₹52.36 Lakh -₹13.35 Lakh ₹47.33 Lakh ₹1.6 Cr -₹54.55 Lakh
Employee Benefit Expense ₹3.85 Cr ₹3.72 Cr ₹3.93 Cr ₹3.67 Cr ₹3.38 Cr ₹3.29 Cr ₹3.21 Cr ₹3.07 Cr ₹2.28 Cr ₹2.84 Cr ₹2.65 Cr ₹2.77 Cr
Finance Costs ₹8.92 Lakh ₹16.13 Lakh ₹28.34 Lakh ₹30.14 Lakh ₹26.11 Lakh ₹28.42 Lakh ₹32.15 Lakh ₹16.15 Lakh ₹27.43 Lakh ₹21.29 Lakh ₹18.67 Lakh ₹17.11 Lakh
Depreciation & Amortisation ₹41.27 Lakh ₹39.29 Lakh ₹39.24 Lakh ₹39.19 Lakh ₹38.76 Lakh ₹38.38 Lakh ₹42.96 Lakh ₹40.05 Lakh ₹45.63 Lakh ₹43.48 Lakh ₹44.13 Lakh ₹44.09 Lakh
Other Expenses ₹3.26 Cr ₹3.12 Cr ₹3.29 Cr ₹2.82 Cr ₹2.58 Cr ₹2.89 Cr ₹2.87 Cr ₹2.27 Cr ₹2.35 Cr ₹2.35 Cr ₹2.49 Cr ₹1.92 Cr
Total Expenses ₹20.03 Cr ₹16.39 Cr ₹21.6 Cr ₹23.08 Cr ₹22.43 Cr ₹19.61 Cr ₹20.03 Cr ₹18.21 Cr ₹18.07 Cr ₹21.3 Cr ₹23.23 Cr ₹16.29 Cr
Profit Before Exceptional Items & Tax ₹61.43 Lakh ₹30.28 Lakh ₹2.24 Cr ₹2.65 Cr ₹1.51 Cr ₹93.65 Lakh ₹95.57 Lakh -₹21.23 Lakh ₹30.34 Lakh ₹60.35 Lakh ₹1.18 Cr -₹53.27 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹61.43 Lakh ₹30.28 Lakh ₹2.24 Cr ₹2.65 Cr ₹1.51 Cr ₹93.65 Lakh ₹95.57 Lakh -₹21.23 Lakh ₹30.34 Lakh ₹60.35 Lakh ₹1.18 Cr -₹53.27 Lakh
Total Tax Expense ₹0 ₹0 ₹0 ₹0 ₹17.54 Lakh ₹0 ₹0 ₹0 ₹0 ₹2.59 Lakh ₹0 ₹0
Net Profit ₹1.52 Cr ₹5.5 Cr ₹7.98 Cr ₹9.58 Cr -₹1.46 Cr -₹2.13 Cr -₹3.96 Cr -₹2.41 Cr -₹9.61 Cr -₹3.88 Cr -₹1.64 Cr -₹4.47 Cr
  attributable to Owners ₹1.49 Cr ₹5.5 Cr - - - - -₹3.96 Cr -₹2.41 Cr - - ₹0 -₹4.47 Cr
  attributable to NCI ₹0 ₹0 - - - - ₹0 ₹0 - - ₹0 ₹0
Other Comprehensive Income -₹3.07 Lakh ₹0 ₹0 ₹0 -₹1.83 Lakh ₹0 ₹0 ₹0 -₹4.34 Lakh ₹0 ₹0 ₹0
Total Comprehensive Income ₹1.49 Cr ₹5.5 Cr ₹7.98 Cr ₹9.58 Cr -₹1.48 Cr -₹2.13 Cr -₹3.96 Cr -₹2.41 Cr -₹9.65 Cr -₹3.88 Cr -₹1.64 Cr -₹4.47 Cr
EBITDA (computed) ₹1.12 Cr ₹85.7 Lakh ₹2.91 Cr ₹3.34 Cr ₹2.16 Cr ₹1.6 Cr ₹1.71 Cr ₹34.97 Lakh ₹1.03 Cr ₹1.25 Cr ₹1.81 Cr ₹7.93 Lakh
Basic EPS ₹0.52 ₹1.87 ₹2.71 ₹3.25 ₹-0.54 ₹-0.82 ₹-1.51 ₹-0.94 ₹-3.77 ₹-1.51 ₹-0.64 ₹-1.75
Diluted EPS ₹0.52 ₹1.87 ₹2.71 ₹3.25 ₹-0.54 ₹-0.82 ₹-1.51 ₹-0.94 ₹-3.77 ₹-1.51 ₹-0.64 ₹-1.75
Latest 12 quarters shown of 23 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
a) Trading ₹23.22 Lakh -₹11.68 Lakh ₹74.37 Lakh ₹70.7 Lakh
b) Manufacturing ₹19.98 Cr ₹88.15 Lakh ₹47.54 Cr ₹24.81 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
a) Trading ₹2.87 Cr -₹6.38 Lakh - -
b) Manufacturing ₹82.87 Cr ₹6.94 Cr - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2020
Revenue from Operations ₹85.74 Cr ₹82.56 Cr ₹79.49 Cr ₹55.54 Cr ₹76.97 Cr ₹69.69 Cr
Other Income ₹1.17 Cr ₹88.31 Lakh ₹95.56 Lakh ₹10.72 Lakh ₹94.76 Lakh ₹40.63 Lakh
Total Income ₹86.91 Cr ₹83.44 Cr ₹80.44 Cr ₹55.65 Cr ₹77.91 Cr ₹70.09 Cr
Cost of Materials Consumed ₹49.61 Cr ₹47.04 Cr ₹44.72 Cr ₹32.33 Cr ₹46.49 Cr ₹49.5 Cr
Purchases of Stock-in-Trade ₹2.25 Cr ₹7.18 Cr ₹10.5 Cr ₹6.12 Cr ₹5.72 Cr ₹61.48 Lakh
Changes in Inventories -₹84.1 Lakh -₹14.79 Lakh ₹1.4 Cr ₹2.01 Cr -₹2.93 Cr -₹3.29 Cr
Employee Benefit Expense ₹15.16 Cr ₹12.96 Cr ₹10.54 Cr ₹11.54 Cr ₹12.8 Cr ₹13.38 Cr
Finance Costs ₹83.53 Lakh ₹1.03 Cr ₹84.49 Lakh ₹76.67 Lakh ₹66.97 Lakh ₹3.35 Cr
Depreciation & Amortisation ₹1.59 Cr ₹1.6 Cr ₹1.77 Cr ₹1.72 Cr ₹1.49 Cr ₹6.65 Cr
Other Expenses ₹12.49 Cr ₹10.55 Cr ₹9.11 Cr ₹9.35 Cr ₹13.01 Cr ₹13.4 Cr
Total Expenses ₹81.1 Cr ₹80.21 Cr ₹78.89 Cr ₹63.84 Cr ₹77.25 Cr ₹83.61 Cr
Profit Before Exceptional Items & Tax ₹5.81 Cr ₹3.23 Cr ₹1.55 Cr -₹8.19 Cr ₹66.6 Lakh -₹13.51 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹5.81 Cr ₹3.23 Cr ₹1.55 Cr -₹8.19 Cr ₹66.6 Lakh -₹13.51 Cr
Total Tax Expense ₹0 ₹17.54 Lakh ₹2.59 Lakh ₹0 ₹0 ₹10.86 Cr
Net Profit ₹5.81 Cr ₹3.05 Cr ₹1.53 Cr -₹8.19 Cr ₹66.6 Lakh -₹24.38 Cr
Other Comprehensive Income -₹3.07 Lakh -₹1.83 Lakh -₹4.34 Lakh -₹3.3 Lakh ₹12.66 Lakh ₹14.73 Lakh
Total Comprehensive Income ₹5.77 Cr ₹3.03 Cr ₹1.49 Cr -₹8.22 Cr ₹79.26 Lakh -₹24.23 Cr
EBITDA (computed) ₹8.23 Cr ₹5.86 Cr ₹4.17 Cr -₹5.71 Cr ₹2.82 Cr -₹3.52 Cr
Basic EPS ₹1.97 ₹1.14 ₹0.58 ₹3.32 ₹0.27 ₹-13.84
Diluted EPS ₹1.97 ₹1.14 ₹0.58 ₹3.32 ₹0.27 ₹-13.84
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹146.36 Cr ₹140.66 Cr ₹94.39 Cr ₹92.42 Cr
Non-current Assets ₹108.95 Cr ₹106.78 Cr ₹63.34 Cr ₹64.82 Cr
Current Assets ₹37.42 Cr ₹33.88 Cr ₹31.05 Cr ₹27.61 Cr
Property, Plant & Equipment ₹13.41 Cr ₹12.51 Cr ₹13.07 Cr ₹14.02 Cr
Inventories ₹11.02 Cr ₹9.2 Cr ₹9.61 Cr ₹11.3 Cr
Trade Receivables ₹16.11 Cr ₹19.99 Cr ₹16.32 Cr ₹12.75 Cr
Cash & Equivalents ₹6.59 Cr ₹4.34 Lakh ₹12.55 Lakh ₹2.33 Lakh
Equity (Net Worth) ₹120.84 Cr ₹115.07 Cr ₹69.53 Cr ₹56.78 Cr
Equity Share Capital ₹29.46 Cr ₹29.46 Cr ₹26.25 Cr ₹24.7 Cr
Borrowings (Non-current) ₹1.19 Cr ₹13.05 Lakh ₹0 ₹0
Borrowings (Current) ₹6.09 Cr ₹5.93 Cr ₹5.04 Cr ₹5.66 Cr
Total Debt (computed) ₹7.28 Cr ₹6.06 Cr ₹5.04 Cr ₹5.66 Cr
Current Liabilities ₹21.81 Cr ₹22.84 Cr ₹23.05 Cr ₹33.02 Cr
Total Liabilities ₹25.52 Cr ₹25.59 Cr ₹24.86 Cr ₹35.64 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹9.29 Cr ₹2.52 Cr -₹9.68 Cr ₹56.26 Lakh ₹3.12 Cr
Investing Cash Flow -₹2.92 Cr -₹45.97 Cr ₹18.22 Lakh -₹39.97 Lakh ₹1.12 Cr
Financing Cash Flow ₹17.09 Lakh ₹43.36 Cr ₹9.6 Cr -₹22.35 Lakh -₹4.22 Cr
Capital Expenditure ₹3.51 Cr ₹92.28 Lakh ₹43.9 Lakh ₹46.75 Lakh ₹1.77 Cr
Free Cash Flow (computed) ₹5.79 Cr ₹1.6 Cr -₹10.12 Cr ₹9.51 Lakh ₹1.35 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹6.54 Cr -₹8.21 Lakh ₹10.24 Lakh -₹6.05 Lakh ₹2.01 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q1 FY24 Q4 FY23
Revenue from Operations ₹20.21 Cr ₹16.57 Cr ₹23.45 Cr ₹25.51 Cr ₹23.32 Cr ₹20.52 Cr ₹20.79 Cr ₹17.93 Cr ₹17.72 Cr ₹21.75 Cr ₹15.7 Cr ₹12.61 Cr
Other Income ₹43.83 Lakh ₹12.5 Lakh ₹39.02 Lakh ₹21.7 Lakh ₹62.06 Lakh ₹2.79 Lakh ₹19.84 Lakh ₹6.93 Lakh ₹65.36 Lakh ₹15.5 Lakh ₹5.48 Lakh ₹1.91 Lakh
Total Income ₹20.65 Cr ₹16.69 Cr ₹23.84 Cr ₹25.73 Cr ₹23.94 Cr ₹20.54 Cr ₹20.99 Cr ₹18 Cr ₹18.38 Cr ₹21.9 Cr ₹15.76 Cr ₹12.63 Cr
Cost of Materials Consumed ₹11.81 Cr ₹9.08 Cr ₹10.42 Cr ₹13.62 Cr ₹13.68 Cr ₹12.17 Cr ₹11.4 Cr ₹9.8 Cr ₹9.74 Cr ₹12.09 Cr ₹10.67 Cr ₹8.34 Cr
Purchases of Stock-in-Trade ₹3.2 Lakh ₹1.49 Cr ₹3 Cr ₹2.41 Cr ₹1.72 Cr ₹1.19 Cr ₹1.24 Cr ₹3.03 Cr ₹3.11 Cr ₹2.9 Cr ₹86.09 Lakh ₹58.66 Lakh
Changes in Inventories ₹57.39 Lakh -₹1.57 Cr ₹29.01 Lakh -₹13.13 Lakh ₹41.12 Lakh -₹59.51 Lakh ₹55.96 Lakh -₹52.36 Lakh -₹13.35 Lakh ₹47.33 Lakh -₹54.55 Lakh -₹71.63 Lakh
Employee Benefit Expense ₹3.85 Cr ₹3.72 Cr ₹3.93 Cr ₹3.67 Cr ₹3.38 Cr ₹3.29 Cr ₹3.21 Cr ₹3.07 Cr ₹2.28 Cr ₹2.84 Cr ₹2.77 Cr ₹2.26 Cr
Finance Costs ₹8.92 Lakh ₹16.13 Lakh ₹28.34 Lakh ₹30.14 Lakh ₹26.11 Lakh ₹28.42 Lakh ₹32.15 Lakh ₹16.15 Lakh ₹27.43 Lakh ₹21.29 Lakh ₹17.11 Lakh ₹18.43 Lakh
Depreciation & Amortisation ₹41.27 Lakh ₹39.29 Lakh ₹39.24 Lakh ₹39.19 Lakh ₹38.76 Lakh ₹38.38 Lakh ₹42.96 Lakh ₹40.05 Lakh ₹45.63 Lakh ₹43.48 Lakh ₹44.09 Lakh ₹43.55 Lakh
Other Expenses ₹3.26 Cr ₹3.12 Cr ₹3.29 Cr ₹2.82 Cr ₹2.55 Cr ₹2.89 Cr ₹2.87 Cr ₹2.27 Cr ₹2.35 Cr ₹2.35 Cr ₹1.92 Cr ₹2.27 Cr
Total Expenses ₹20.03 Cr ₹16.39 Cr ₹21.6 Cr ₹23.08 Cr ₹22.39 Cr ₹19.61 Cr ₹20.03 Cr ₹18.21 Cr ₹18.07 Cr ₹21.3 Cr ₹16.29 Cr ₹13.35 Cr
Profit Before Exceptional Items & Tax ₹61.43 Lakh ₹30.28 Lakh ₹2.24 Cr ₹2.65 Cr ₹1.55 Cr ₹93.65 Lakh ₹95.57 Lakh -₹21.23 Lakh ₹30.34 Lakh ₹60.35 Lakh -₹53.27 Lakh -₹72 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹61.43 Lakh ₹30.28 Lakh ₹2.24 Cr ₹2.65 Cr ₹1.55 Cr ₹93.65 Lakh ₹95.57 Lakh -₹21.23 Lakh ₹30.34 Lakh ₹60.35 Lakh -₹53.27 Lakh -₹72 Lakh
Total Tax Expense ₹0 ₹0 ₹0 ₹0 ₹17.54 Lakh ₹0 ₹0 ₹0 ₹0 ₹2.59 Lakh ₹0 ₹0
Net Profit ₹61.43 Lakh ₹30.28 Lakh ₹2.24 Cr ₹2.65 Cr ₹1.37 Cr ₹93.65 Lakh ₹95.57 Lakh -₹21.23 Lakh ₹30.34 Lakh ₹57.76 Lakh -₹53.27 Lakh -₹72 Lakh
Other Comprehensive Income -₹3.07 Lakh ₹0 ₹0 ₹0 -₹1.83 Lakh ₹0 ₹0 ₹0 -₹4.34 Lakh ₹0 ₹0 -₹3.3 Lakh
Total Comprehensive Income ₹58.36 Lakh ₹30.28 Lakh ₹2.24 Cr ₹2.65 Cr ₹1.35 Cr ₹93.65 Lakh ₹95.57 Lakh -₹21.23 Lakh ₹26 Lakh ₹57.76 Lakh -₹53.27 Lakh -₹75.3 Lakh
EBITDA (computed) ₹1.12 Cr ₹85.7 Lakh ₹2.91 Cr ₹3.34 Cr ₹2.2 Cr ₹1.6 Cr ₹1.71 Cr ₹34.97 Lakh ₹1.03 Cr ₹1.25 Cr ₹7.93 Lakh -₹10.02 Lakh
Basic EPS ₹0.21 ₹0.10 ₹0.76 ₹0.90 ₹0.51 ₹0.36 ₹0.36 ₹-0.08 ₹0.10 ₹0.23 ₹-0.22 ₹0.29
Diluted EPS ₹0.21 ₹0.10 ₹0.76 ₹0.90 ₹0.51 ₹0.36 ₹0.36 ₹-0.08 ₹0.10 ₹0.23 ₹-0.22 ₹0.29
Latest 12 quarters shown of 23 on record.
Segment · Q4 FY26 (latest quarter) Revenue Result (PBIT) Assets Liabilities
a) Trading ₹23.22 Lakh -₹11.68 Lakh ₹74.37 Lakh ₹70.7 Lakh
b) Manufacturing ₹19.98 Cr ₹88.15 Lakh ₹47.54 Cr ₹24.81 Cr
Segment · FY 2026 (annual) Revenue Result (PBIT) Assets Liabilities
a) Trading ₹2.87 Cr -₹6.38 Lakh - -
b) Manufacturing ₹82.87 Cr ₹6.94 Cr - -
Want more history and ratios?
You're viewing the latest exchange-filed financials for Brooks Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Brooks Laboratories Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 52.62%, foreign institutional investors hold 0.17%, domestic institutional investors hold 10.38%, retail and other public shareholders hold 36.84% of Brooks Laboratories Limited. The company had 10,741 shareholders on record.

Promoters: 52.62%DII (Domestic Institutional): 10.38%FII (Foreign Institutional): 0.17%Retail & Others: 36.84%
Mar 2026
QUARTER
52.62% Promoters
10.38% DII (Domestic Institutional)
0.17% FII (Foreign Institutional)
36.84% Retail & Others
Promoter holding - history
Now 52.62% · Mar 2026High 66.41% · Mar 2020Low 52.62% · Jan 2025
51%55.3%59.5%63.8%68%Dec 2015Sep 2018Mar 2021Sep 2023Mar 2026Dec 2015: 60.62%Mar 2016: 60.62%Jun 2016: 60.62%Sep 2016: 60.62%Dec 2016: 60.62%Mar 2017: 60.62%Jun 2017: 60.62%Sep 2017: 60.62%Dec 2017: 60.62%Mar 2018: 60.62%Jun 2018: 60.62%Sep 2018: 60.62%Dec 2018: 60.62%Mar 2019: 60.62%Jun 2019: 60.62%Jul 2019: 62.11%Sep 2019: 62.58%Dec 2019: 62.58%Mar 2020: 66.41%Jun 2020: 66.41%Sep 2020: 66.41%Dec 2020: 66.41%Mar 2021: 66.41%Jun 2021: 66.41%Sep 2021: 66.41%Dec 2021: 66.41%Mar 2022: 66.41%Jun 2022: 66.41%Sep 2022: 66.41%Dec 2022: 66.41%Mar 2023: 66.41%Jun 2023: 66.41%Aug 2023: 63.59%Sep 2023: 63.59%Dec 2023: 63.59%Mar 2024: 63.59%Jun 2024: 63.59%Sep 2024: 63.59%Dec 2024: 59.06%Jan 2025: 52.62%Mar 2025: 52.62%Jun 2025: 52.62%Sep 2025: 52.62%Dec 2025: 52.62%Mar 2026: 52.62%66.41%52.62%52.62%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Jan 2025
Promoters52.62%52.62%52.62%52.62%52.62%52.62%
Public47.38%47.38%47.38%47.38%47.38%47.38%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters52.62%52.62%63.59%66.41%66.41%66.41%66.41%60.62%60.62%60.62%60.62%
Public47.38%47.38%36.41%33.59%33.59%33.59%33.59%39.38%39.38%39.38%39.38%
Promoter change (YoY, %pts)+0.00-10.97-2.82+0.00+0.00+0.00+5.79+0.00+0.00+0.00-

Board & Governance of Brooks Laboratories Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Brooks Laboratories Limited has 6 directors - 3 independent and 3 executive.

DirectorPositionOn board sinceListed boards
JITENDRA PRATAP SINGH Executive Director 2022-11-23 1
DURGA SHANKAR MAITY Executive Director 2023-07-07 1
BHUSHAN SINGH RANA Executive Director 2023-08-23 1
USHA SINGH Non-Executive - Independent Director 2024-08-07 1
LALIT MAHAJAN Non-Executive - Independent Director 2024-08-07 1
MANAV MAHAJAN Non-Executive - Independent Director 2024-09-28 1
Board Committees
CommitteeMembers
Audit Committee USHA SINGH (Chairperson), LALIT MAHAJAN, BHUSHAN SINGH RANA
Nomination and remuneration committee USHA SINGH (Chairperson), LALIT MAHAJAN, MANAV MAHAJAN
Stakeholders Relationship Committee USHA SINGH (Chairperson), LALIT MAHAJAN, BHUSHAN SINGH RANA
Corporate Social Responsibility Committee LALIT MAHAJAN (Chairperson), BHUSHAN SINGH RANA, JITENDRA PRATAP SINGH
Fund Raising Committee USHA SINGH (Chairperson), LALIT MAHAJAN, DURGA SHANKAR MAITY
FINANCE COMMITTEE LALIT MAHAJAN (Chairperson), BHUSHAN SINGH RANA, JITENDRA PRATAP SINGH

Group Structure of Brooks Laboratories Limited

Brooks Laboratories Limited has 1 joint venture and 1 associated company. This group structure data is as of FY 2024. The corporate group structure reflects Brooks Laboratories Limited's business expansion strategy and organizational complexity.

1
Joint ventures
1
Associated companies

Charges & Borrowings of Brooks Laboratories Limited

Open charges
₹75.81 Cr
Satisfied charges
₹115.74 Cr
Breakdown by lending institutions
Others₹75.81 Cr
Latest charge details
DateLenderAmountStatus
19 Dec 2024 Others ₹63.62 Cr Open
30 Jun 2024 Others ₹9.7 Lakh Open
19 Apr 2024 Others ₹9.04 Lakh Open
30 Oct 2014 Others ₹12 Cr Open
25 Mar 2021 Indian Bank ₹19.39 Cr Satisfied

Total charge records: 23 View all charges

Employees and EPFO Compliance at Brooks Laboratories Limited

Brooks Laboratories Limited has a workforce of 289 employees as of Mar 31, 2025.

Employee count
289
Active EPFO establishments
1
Employee growth
5.09%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Brooks Laboratories Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Brooks Laboratories Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Brooks Laboratories Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Brooks Laboratories Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Brooks Laboratories Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Brooks Laboratories Limited

MSME Payment Delays by Brooks Laboratories Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Brooks Laboratories Limited

Subsidiaries & Group Companies of Brooks Laboratories Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Brooks Laboratories Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Brooks Laboratories Limited

MCA Filings & Documents of Brooks Laboratories Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Brooks Laboratories Limited

Charges
31 Dec 2024
A charge registered on 25 Mar 2021 via Charge ID 100444147 with Indian Bank was fully satisfied on 31 Dec 2024.
Charges
19 Dec 2024
A charge with Others amounted to Rs. 63.62 Cr with Charge ID 101043257 was registered on 19 Dec 2024.
Directors
28 Sep 2024
Manav Mahajan was appointed as a Director on 28 Sep 2024 & has been associated with this company since 1 year 9 months.
Activity
19 Sep 2024
Brooks Laboratories Limited last Annual general meeting of members was held on 19 Sep 2024 as per latest MCA records.
Charges
05 Sep 2024
A charge with Others of Rs. 12.00 Cr registered on 30 Oct 2014 with Charge ID 10538996 was modified on 05 Sep 2024.
Directors
07 Aug 2024
Usha Singh was appointed as a Director on 07 Aug 2024 & has been associated with this company since 1 year 11 months.

Recent News on Brooks Laboratories Limited

Frequently Asked Questions about Brooks Laboratories Limited

Brooks Laboratories Limited is an active public limited company in the pharma sector based in Nalagarh, Himachal Pradesh, India. It was incorporated on 23 January 2002 (24+ years old) and is registered under CIN L24232HP2002PLC000267. Listed on BSE: 533543 and NSE: BROOKS. The company has 289 employees.

Brooks Laboratories Limited reported revenue of ₹83.44 Cr for FY 2025 (up 4.00% YoY).

The current directors of Brooks Laboratories Limited are:

The primary industry of Brooks Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Brooks Laboratories Limited is listed on both BSE (code: 533543) and NSE (symbol: BROOKS).

Brooks Laboratories Limited can be reached at the registered office: Village Kishanpura Nalagarh Road Baddi, Himachal Pradesh, India – 174101, or through the website brookslabs.net.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available